BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 23564159)

  • 1. A pilot study to profile salivary angiogenic factors to detect head and neck cancers.
    van der Merwe L; Wan Y; Cheong HJ; Perry C; Punyadeera C
    BMC Cancer; 2018 Jul; 18(1):734. PubMed ID: 30001714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Possible Role for TNF-α in Coordinating Inflammation and Angiogenesis in Chronic Liver Disease and Hepatocellular Carcinoma.
    Hammam O; Mahmoud O; Zahran M; Sayed A; Salama R; Hosny K; Farghly A
    Gastrointest Cancer Res; 2013 Jul; 6(4):107-14. PubMed ID: 24147158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SERUM LEPTIN LEVENS AND HEPATOCELLULAR CARCINOMA: REVIEW ARTICLE.
    Andrighetto LV; Poziomyck AK
    Arq Bras Cir Dig; 2016; 29(4):276-278. PubMed ID: 28076486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of
    Ogawa M; Moriyama M; Nakamura H; Shibata T; Kuroda K; Sugitani M
    J Clin Biochem Nutr; 2024 Mar; 74(2):169-178. PubMed ID: 38510682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte specific deletion of c-Met leads to the development of severe non-alcoholic steatohepatitis in mice.
    Kroy DC; Schumacher F; Ramadori P; Hatting M; Bergheim I; Gassler N; Boekschoten MV; Müller M; Streetz KL; Trautwein C
    J Hepatol; 2014 Oct; 61(4):883-90. PubMed ID: 24845607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between immunologic markers and cirrhosis in individuals with chronic hepatitis B.
    Argirion I; Pfeiffer RM; Lam TK; O'Brien TR; Yu K; McGlynn KA; Petrick JL; Pinto L; Chen CJ; Lee MH; Hildesheim A; Yang HI; Koshiol J
    Sci Rep; 2021 Nov; 11(1):21194. PubMed ID: 34782638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. System-Wide Pollution of Biomedical Data: Consequence of the Search for Hub Genes of Hepatocellular Carcinoma Without Spatiotemporal Consideration.
    Sharma A; Colonna G
    Mol Diagn Ther; 2021 Jan; 25(1):9-27. PubMed ID: 33475988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of leptin and adiponectin with hepatocellular carcinoma risk and prognosis: a combination of traditional, survival, and dose-response meta-analysis.
    Zhang L; Yuan Q; Li M; Chai D; Deng W; Wang W
    BMC Cancer; 2020 Nov; 20(1):1167. PubMed ID: 33256658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Domperidone use and risk of primary liver cancer in the Clinical Practice Research Datalink.
    Thistle JE; Petrick JL; Yang B; Bradley MC; Graubard BI; McGlynn KA
    Cancer Epidemiol; 2018 Aug; 55():170-175. PubMed ID: 29986235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of
    Zhang S; Jiang J; Chen Z; Wang Y; Tang W; Liu C; Liu L; Chen Y
    Onco Targets Ther; 2018; 11():2083-2089. PubMed ID: 29695916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble intercellular adhesion molecule-1 is associated with hepatocellular carcinoma risk: multiplex analysis of serum markers.
    Chen VL; Le AK; Podlaha O; Estevez J; Li B; Vutien P; Chang ET; Rosenberg-Hasson Y; Pflanz S; Jiang Z; Ge D; Gaggar A; Nguyen MH
    Sci Rep; 2017 Sep; 7(1):11169. PubMed ID: 28894136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the seleno-transcriptome expression between human non-cancerous mammary epithelial cells and two human breast cancer cell lines.
    Rusolo F; Capone F; Pasquale R; Angiolillo A; Colonna G; Castello G; Costantini M; Costantini S
    Oncol Lett; 2017 Apr; 13(4):2411-2417. PubMed ID: 28454412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of soluble factors in conditioned media derived from primary cultures of cirrhotic liver of biliary atresia.
    Yamazaki T; Wakai M; Enosawa S; Tokiwa T
    In Vitro Cell Dev Biol Anim; 2017 Jun; 53(6):564-573. PubMed ID: 28364348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human growth hormone and human prolactin function as autocrine/paracrine promoters of progression of hepatocellular carcinoma.
    Kong X; Wu W; Yuan Y; Pandey V; Wu Z; Lu X; Zhang W; Chen Y; Wu M; Zhang M; Li G; Tan S; Qian P; Perry JK; Lobie PE; Zhu T
    Oncotarget; 2016 May; 7(20):29465-79. PubMed ID: 27102295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer biomarker profiling in patients with chronic hepatitis C virus, liver cirrhosis and hepatocellular carcinoma.
    Costantini S; Capone F; Maio P; Guerriero E; Colonna G; Izzo F; Castello G
    Oncol Rep; 2013 Jun; 29(6):2163-8. PubMed ID: 23564159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum concentrations of human hepatocyte growth factor is a useful indicator for predicting the occurrence of hepatocellular carcinomas in C-viral chronic liver diseases.
    Yamagamim H; Moriyama M; Matsumura H; Aoki H; Shimizu T; Saito T; Kaneko M; Shioda A; Tanaka N; Arakawa Y
    Cancer; 2002 Aug; 95(4):824-34. PubMed ID: 12209727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma.
    Hsia CY; Huo TI; Chiang SY; Lu MF; Sun CL; Wu JC; Lee PC; Chi CW; Lui WY; Lee SD
    Eur J Surg Oncol; 2007 Mar; 33(2):208-12. PubMed ID: 17140760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of epidermal growth factor receptor and transforming growth factor-α on hepatitis C virus-induced hepatocarcinogenesis.
    Badawy AA; El-Hindawi A; Hammam O; Moussa M; Gabal S; Said N
    APMIS; 2015 Oct; 123(10):823-31. PubMed ID: 26279457
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.